Agreements reached under this partnership
Business alliance- 1
The parties will analyze and evaluate protein biomarkers using specimens from patients in the acute phase of spinal cord injury collected in clinical trials conducted to date.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of this matter on the company's financial results is minor.
| Item | Details |
|---|---|
| Name of alliance partner | Keio University School of Medicine |
| Alliance partner's location | Shinjuku-ku, Tokyo |
| Type of alliance | Business alliance |
| Details of the alliance | The parties will analyze and evaluate protein biomarkers using specimens from patients in the acute phase of spinal cord injury collected in clinical trials conducted to date. |
| Impact on Business Performance | The impact of this matter on the company's financial results is minor. |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The findings from the joint research are intended to improve the evaluation of treatment efficacy and the accuracy of predictions of natural recovery during the acute phase of spinal cord injury, thereby contributing to more advanced analyses of clinical trials and the development of more appropriate treatment strategies. The company expects the impact on its financial results to be minor.